ARL14EPL
gene geneOn this page
Summary
ARL14EPL (ARF like GTPase 14 effector protein like, HGNC:44201) is a protein-coding gene on chromosome 5q23.1, encoding ARL14 effector protein-like (P0DKL9).
At a glance
- Clinical variants (ClinVar): 46 total
- MANE Select transcript:
NM_001195581
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:44201 |
| Approved symbol | ARL14EPL |
| Name | ARF like GTPase 14 effector protein like |
| Location | 5q23.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000268223 |
| Ensembl biotype | protein_coding |
| Entrez | 644100 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000601302, ENST00000686077
RefSeq mRNA: 3 — MANE Select: NM_001195581
NM_001195581, NM_001385024, NM_001393974
CCDS: CCDS59490
Canonical transcript exons
ENST00000686077 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003787001 | 116051457 | 116051561 |
| ENSE00003828134 | 116054014 | 116054153 |
| ENSE00003926708 | 116032472 | 116032505 |
| ENSE00003929349 | 116058725 | 116059489 |
Expression profiles
Bgee: expression breadth broad, 16 present calls, max score 91.02.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.2186 / max 78.9765, expressed in 48 samples.
FANTOM5 promoters (6 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 58070 | 0.0972 | 20 |
| 58068 | 0.0507 | 13 |
| 58069 | 0.0242 | 8 |
| 58066 | 0.0184 | 7 |
| 58067 | 0.0172 | 5 |
| 58065 | 0.0109 | 2 |
Top tissues by expression
110 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 91.02 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 48.90 | gold quality |
| placenta | UBERON:0001987 | 43.79 | gold quality |
| lymph node | UBERON:0000029 | 42.38 | gold quality |
| vermiform appendix | UBERON:0001154 | 40.76 | gold quality |
| bone marrow cell | CL:0002092 | 40.40 | gold quality |
| monocyte | CL:0000576 | 39.85 | silver quality |
| endometrium | UBERON:0001295 | 39.61 | gold quality |
| leukocyte | CL:0000738 | 39.40 | silver quality |
| granulocyte | CL:0000094 | 39.39 | gold quality |
| tonsil | UBERON:0002372 | 38.54 | gold quality |
| calcaneal tendon | UBERON:0003701 | 37.76 | gold quality |
| right lung | UBERON:0002167 | 37.45 | silver quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| sural nerve | UBERON:0015488 | 36.47 | gold quality |
| adrenal tissue | UBERON:0018303 | 36.06 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 34.88 | silver quality |
| gall bladder | UBERON:0002110 | 33.63 | gold quality |
| kidney | UBERON:0002113 | 33.56 | silver quality |
| adipose tissue | UBERON:0001013 | 33.53 | silver quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| muscle tissue | UBERON:0002385 | 32.21 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| urinary bladder | UBERON:0001255 | 31.99 | silver quality |
| pituitary gland | UBERON:0000007 | 31.35 | gold quality |
| fallopian tube | UBERON:0003889 | 29.91 | silver quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.44 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
10 targeting ARL14EPL, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3185 | 99.99 | 68.12 | 1959 |
| HSA-MIR-511-3P | 99.99 | 68.85 | 1467 |
| HSA-MIR-4307 | 99.82 | 70.45 | 3374 |
| HSA-MIR-3679-3P | 99.64 | 69.88 | 1599 |
| HSA-MIR-642A-3P | 99.23 | 67.67 | 1258 |
| HSA-MIR-642B-3P | 99.23 | 67.67 | 1258 |
| HSA-MIR-455-3P | 98.94 | 67.68 | 878 |
| HSA-MIR-4700-5P | 98.63 | 67.43 | 1915 |
| HSA-MIR-924 | 97.78 | 66.21 | 681 |
| HSA-MIR-6802-3P | 97.29 | 65.42 | 613 |
Cross-species orthologs
6 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | zgc:153292 | ENSDARG00000070458 |
| danio_rerio | ENSDARG00000076082 | |
| danio_rerio | zgc:163143 | ENSDARG00000076437 |
| mus_musculus | Arl14epl | ENSMUSG00000073568 |
| rattus_norvegicus | Arl14epl | ENSRNOG00000025590 |
| drosophila_melanogaster | CG13894 | FBGN0035157 |
Paralogs (7): THAP3 (ENSG00000041988), THAP1 (ENSG00000131931), ARL14EP (ENSG00000152219), THAP8 (ENSG00000161277), THAP2 (ENSG00000173451), THAP6 (ENSG00000174796), THAP7 (ENSG00000184436)
Protein
Protein identifiers
ARL14 effector protein-like — P0DKL9 (reviewed: P0DKL9)
All UniProt accessions (1): P0DKL9
RefSeq proteins (3): NP_001182510, NP_001371953, NP_001380903 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR029264 | ARF7EP_C | Domain |
| IPR053130 | ARL14_effector | Family |
Pfam: PF14949
UniProt features (2 total): chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P0DKL9-F1 | 81.42 | 0.55 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 9 (showing top):
HES2_TARGET_GENES, IGLV5_37_TARGET_GENES, LHX9_TARGET_GENES, ZNF175_TARGET_GENES, MIR3185, MIR511_3P, HBZ_TARGET_GENES, ZBTB44_TARGET_GENES, chr5q23
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
204 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ARL14EPL | CLEC18B | Q6UXF7 | 575 |
| ARL14EPL | ANO8 | Q9HCE9 | 497 |
| ARL14EPL | BICDL1 | Q6ZP65 | 439 |
| ARL14EPL | TENM2 | Q9NT68 | 378 |
| ARL14EPL | CSRNP1 | Q96S65 | 368 |
| ARL14EPL | DEFA6 | Q01524 | 354 |
| ARL14EPL | ATF7IP | Q6VMQ6 | 348 |
| ARL14EPL | SUOX | P51687 | 340 |
| ARL14EPL | ITGA11 | Q9UKX5 | 300 |
| ARL14EPL | OSCP1 | Q8WVF1 | 294 |
| ARL14EPL | PDRG1 | Q9NUG6 | 292 |
| ARL14EPL | CDO1 | P78513 | 270 |
| ARL14EPL | NAA50 | Q9GZZ1 | 253 |
| ARL14EPL | TMEM65 | Q6PI78 | 252 |
| ARL14EPL | NHLRC2 | Q8NBF2 | 252 |
IntAct
0 interactions, top by confidence:
BioGRID (1): ARL14EPL (Negative Genetic)
ESM2 similar proteins: A0PJ23, A9JR22, A9JR44, B0BLK0, B0BLK7, B0BLK9, B2C4J2, B2MW50, B2ZDY1, G5EED4, J7H5K9, O10310, O73557, O74772, P05075, P05076, P05077, P0C9W8, P0C9W9, P0DKL9, P18541, P19325, P27426, P36707, P41457, P41474, Q06834, Q11107, Q197D3, Q27YE2, Q27YE6, Q3UKZ7, Q5UPV2, Q65209, Q6BET5, Q6IUF9, Q6IVU5, Q6R7A2, Q6R7D2, Q6R7D3
Diamond homologs: P0DKL9, Q3UKZ7, Q5EA92, Q5FVK8, Q8BIX3, Q8N8R7
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
46 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 40 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1043 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 5:116049602:C:G | donor_gain | 1.0000 |
| 5:116051455:A:G | acceptor_gain | 1.0000 |
| 5:116052345:C:G | donor_gain | 1.0000 |
| 5:116054012:A:AG | acceptor_gain | 1.0000 |
| 5:116054013:G:GG | acceptor_gain | 1.0000 |
| 5:116054154:G:GG | donor_gain | 1.0000 |
| 5:116058723:A:AG | acceptor_gain | 1.0000 |
| 5:116058724:G:GG | acceptor_gain | 1.0000 |
| 5:116032501:GAAGC:G | donor_gain | 0.9900 |
| 5:116032504:GC:G | donor_gain | 0.9900 |
| 5:116032506:G:GG | donor_gain | 0.9900 |
| 5:116034106:GGCTC:G | donor_gain | 0.9900 |
| 5:116051454:A:AG | acceptor_gain | 0.9900 |
| 5:116051454:AAGT:A | acceptor_gain | 0.9900 |
| 5:116051456:G:GG | acceptor_gain | 0.9900 |
| 5:116054001:ATTT:A | acceptor_loss | 0.9900 |
| 5:116054010:ATAG:A | acceptor_loss | 0.9900 |
| 5:116054013:G:A | acceptor_loss | 0.9900 |
| 5:116054013:GC:G | acceptor_gain | 0.9900 |
| 5:116054013:GCA:G | acceptor_gain | 0.9900 |
| 5:116054013:GCAA:G | acceptor_gain | 0.9900 |
| 5:116054013:GCAAC:G | acceptor_gain | 0.9900 |
| 5:116054150:ACAAG:A | donor_loss | 0.9900 |
| 5:116054151:CAAG:C | donor_loss | 0.9900 |
| 5:116054151:CAAGT:C | donor_loss | 0.9900 |
| 5:116054152:AAGT:A | donor_loss | 0.9900 |
| 5:116054153:AGTA:A | donor_loss | 0.9900 |
| 5:116054153:AGTAA:A | donor_loss | 0.9900 |
| 5:116054154:GTA:G | donor_loss | 0.9900 |
| 5:116054154:GTAA:G | donor_loss | 0.9900 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000049300 (5:116045237 A>C), RS1000090750 (5:116042182 G>A,T), RS1000155055 (5:116034808 T>C), RS1000157337 (5:116041111 A>G), RS1000211637 (5:116041352 T>C), RS1000241779 (5:116056061 G>A), RS1000310513 (5:116052210 G>A,C), RS1000315189 (5:116036175 T>C), RS1000468520 (5:116030810 T>C), RS1000507203 (5:116045510 A>G), RS1000519266 (5:116031060 G>A), RS1000530940 (5:116038524 T>C), RS1000771157 (5:116036533 ATG>A), RS1000842578 (5:116032505 C>A,G,T), RS1000957756 (5:116057823 A>C,G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
12 total (human), top 12 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Cadmium Chloride | decreases expression, increases abundance, increases expression | 3 |
| arsenite | affects binding, decreases reaction | 1 |
| sodium arsenite | increases expression | 1 |
| benzo(e)pyrene | decreases methylation | 1 |
| abrine | increases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Cadmium | increases expression, increases abundance | 1 |
| Dichlorodiphenyl Dichloroethylene | decreases expression | 1 |
| Methapyrilene | decreases methylation | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Tretinoin | increases expression | 1 |
| Okadaic Acid | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.